8-K: Tenon Medical Faces Nasdaq Delisting Notice Due to Insufficient Publicly Held Shares

Tenon Medical received a notification from Nasdaq for not meeting the minimum publicly held shares requirement following a recent reverse stock split, but plans to regain compliance through a public offering.

Summary

• Tenon Medical received a notice from Nasdaq on September 9, 2024, stating they do not meet the minimum 500,000 publicly held shares requirement.
• This non-compliance is a result of a 1-for-8 reverse stock split on September 6, 2024, which reduced the outstanding shares from 4,081,767 to 510,221.
• Currently, only 490,364 of these shares qualify as publicly held, falling short of the Nasdaq requirement.
• Tenon Medical has until October 24, 2024, to submit a plan to regain compliance.
• The company intends to regain compliance in September through a public offering of common stock.
• The Nasdaq notification does not immediately affect the listing of Tenon Medical's stock.

Sentiment

Score: 3

Explanation: The document indicates a negative event (delisting notice) but also includes a plan to rectify the situation (public offering). The overall sentiment is negative due to the compliance issue, but the plan provides some hope for recovery.

Positives

• Tenon Medical has a plan to regain compliance with Nasdaq's minimum float requirement through a public offering.
• The Nasdaq notification does not immediately affect the listing of the company's stock.

Negatives

• Tenon Medical is currently not in compliance with Nasdaq's minimum publicly held shares requirement.
• The reverse stock split, while intended to increase share price, resulted in a reduction of publicly held shares below the required threshold.

Risks

• There is a risk that Tenon Medical may not be able to successfully complete the public offering in time to regain compliance.
• Failure to regain compliance could lead to delisting from the Nasdaq Capital Market.
• The company's stock price could be negatively impacted by the delisting notice and the uncertainty surrounding its compliance plan.

Future Outlook

Tenon Medical expects to regain compliance with Nasdaq's minimum float requirement in September through the consummation of a public offering of its common stock.

Management Comments

• The company expects to regain compliance with the Minimum Float Requirement in September through the consummation of a public offering of its common stock.

Industry Context

This announcement highlights the challenges faced by smaller companies in maintaining listing requirements, especially after corporate actions like reverse stock splits. It is not uncommon for companies to use public offerings to raise capital and meet listing requirements.

Comparison to Industry Standards

• Many small-cap companies face similar challenges in maintaining Nasdaq listing requirements, particularly the minimum float requirement.
• Reverse stock splits are a common strategy to increase share price, but they can sometimes lead to issues with the number of publicly held shares.
• Other companies in the medical device sector, such as Xtant Medical Holdings, Inc. (XTNT) and Titan Medical Inc. (TMDI), have also faced similar compliance issues and have used public offerings to raise capital and maintain their listings.

Stakeholder Impact

• Shareholders may experience uncertainty and potential stock price volatility due to the delisting notice.
• Employees may be concerned about the company's future if it fails to regain compliance.
• Creditors and suppliers may also be concerned about the company's financial stability.

Next Steps

• Tenon Medical needs to submit a plan to Nasdaq by October 24, 2024, to regain compliance.
• The company plans to complete a public offering of its common stock in September.

Key Dates

Keywords

Nasdaq, delisting, publicly held shares, reverse stock split, compliance, public offering, TNON, minimum float requirement